Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by ...

With Senn's expertise and infrastructure, Granules aims to scale up its innovation capabilities and diversify its portfolio into complex and next-gen therapeutics.

This >€500 million investment will feature multiple manufacturing lines capable of supporting small, medium, and large-scale peptide production with small- to large-scale Solid Phase Peptide ...